https://www.g3therapeutics.com/ daily 1.0 https://www.g3therapeutics.com/news/interview-dr-szilard-voros-ceo-and-co-founder-global-genomics-group 2019-11-15T10:45:33+00:00 0.5 https://www.g3therapeutics.com/news/3-pillars-understanding-cardiovascular-disease 2019-11-15T10:48:54+00:00 0.5 https://www.g3therapeutics.com/news/identification-novel-cardiovascular-disease-pathways-biomarkers 2019-11-15T10:50:32+00:00 0.5 https://www.g3therapeutics.com/news/omics-overdrive 2019-11-15T10:52:11+00:00 0.5 https://www.g3therapeutics.com/news/global-genomics-group-g3-announces-completion-enrollment-global-study-7500-patients 2019-11-11T16:33:48+00:00 0.5 https://www.g3therapeutics.com/news/global-genomics-group-g3-completes-patient-enrollment-discovery-cohort-global-study-ahead 2019-11-11T16:38:38+00:00 0.5 https://www.g3therapeutics.com/news/g3-quintiles-enter-target-discovery-alliance-0 2019-11-11T16:40:46+00:00 0.5 https://www.g3therapeutics.com/news/global-genomics-group-g3-and-caprion-partner-global-study-identify-cardiovascular-disease-0 2019-11-11T16:43:02+00:00 0.5 https://www.g3therapeutics.com/news/global-genomics-group-g3-appoints-harry-chip-davis-zetiar-inventor-chief-drug-development 2019-11-11T16:47:14+00:00 0.5 https://www.g3therapeutics.com/news/omixon-collaborates-g3-and-genomics-england-validate-hla-genotyping-wgs-data 2019-11-15T10:31:47+00:00 0.5 https://www.g3therapeutics.com/news/global-design-manuscript-published-journal-cardiovascular-computed-tomography 2019-11-15T10:33:32+00:00 0.5 https://www.g3therapeutics.com/news/global-genomics-group-g3-partners-sanofi-identify-new-signaling-pathways-atherosclerotic 2019-11-15T10:35:04+00:00 0.5 https://www.g3therapeutics.com/news/global-genomics-group-g3-and-gns-healthcare-report-preliminary-results-largest-ever-study 2019-11-15T10:36:42+00:00 0.5 https://www.g3therapeutics.com/news/global-genomics-group-and-datavant-announce-strategic-partnership-improve-design-and 2019-11-15T10:38:23+00:00 0.5 https://www.g3therapeutics.com/news/global-genomics-group-g3-presents-data-first-time-exact-size-lipoprotein-particles-cause 2019-11-15T10:39:57+00:00 0.5 https://www.g3therapeutics.com/news/global-genomics-group-g3-granted-patent-breakthrough-diagnostic-blood-test-plaque-detection 2019-11-15T10:42:06+00:00 0.5 https://www.g3therapeutics.com/news/valo-announces-exclusive-partnership-g3-worlds-largest-and-detailed-cardio-metabolic-datasets 2021-01-06T09:57:25+00:00 0.5 https://www.g3therapeutics.com/pharmaceutical-pipeline 2019-11-28T14:34:12+00:00 0.5 https://www.g3therapeutics.com/about-us 2019-11-28T12:37:13+00:00 0.5 https://www.g3therapeutics.com/contact 2019-11-27T16:53:37+00:00 0.5 https://www.g3therapeutics.com/news 2019-11-27T17:01:29+00:00 0.5 https://www.g3therapeutics.com/our-platform-deep-discovery 2019-11-28T14:35:24+00:00 0.5 https://www.g3therapeutics.com/partners-investors 2019-11-27T16:58:06+00:00 0.5 https://www.g3therapeutics.com/pillar-1-deep-quantitative-precision-phenotyping 2019-11-28T14:32:04+00:00 0.5 https://www.g3therapeutics.com/pillar-2-deep-panomic-molecular-profiling 2019-11-28T12:39:33+00:00 0.5 https://www.g3therapeutics.com/pillar-3-deep-learning-ai-ml-bioinformatics 2019-11-28T14:30:54+00:00 0.5 https://www.g3therapeutics.com/publications 2019-11-27T17:01:53+00:00 0.5